About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Setd4tm1c(KOMP)Wtsi
targeted mutation 1c, Wellcome Trust Sanger Institute
MGI:6505434
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Setd4tm1c(KOMP)Wtsi/Setd4tm1c(KOMP)Wtsi
Trp53tm1Brn/Trp53tm1Brn
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6N MGI:6695303
cn2
Setd4tm1c(KOMP)Wtsi/Setd4tm1c(KOMP)Wtsi
Trp53tm1Brn/Trp53+
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6N MGI:6695305
cn3
Setd4tm1c(KOMP)Wtsi/Setd4tm1c(KOMP)Wtsi
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
involves: 129S4/SvJae * C57BL/6 * C57BL/6N MGI:6695300


Genotype
MGI:6695303
cn1
Allelic
Composition
Setd4tm1c(KOMP)Wtsi/Setd4tm1c(KOMP)Wtsi
Trp53tm1Brn/Trp53tm1Brn
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
Genetic
Background
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6N
Cell Lines EPD0225_5_D10
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(cre/ERT2)Tyj mutation (3 available); any Gt(ROSA)26Sor mutation (942 available)
Setd4tm1c(KOMP)Wtsi mutation (0 available); any Setd4 mutation (28 available)
Trp53tm1Brn mutation (18 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• after exposure to 4 weekly 2 Gy of total body gamma-irradiation, most tamoxifen-treated adult mice die within 100 days post irradiation

neoplasm
• gamma-irradiated tamoxifen-treated mice die mainly of non-disseminated thymic lymphomas, unlike mice that are homozygous for Setd4tm1c(KOMP)Wtsiand heterozygous for Gt(ROSA)26Sortm1(cre/ERT2)Tyj where tumors are widely disseminated to other organs
• in gamma-irradiated tamoxifen-treated mice, thymic lymphomas are significantly larger in size/weight relative to those in mice that are only homozygous for Setd4tm1c(KOMP)Wtsiand heterozygous for Gt(ROSA)26Sortm1(cre/ERT2)Tyj
• after exposure to 4 weekly 2 Gy of total body gamma-irradiation, tamoxifen-treated adult mice fail to display a delay in the development of radiation-induced thymic lymphomas
• sham-irradiated, tamoxifen-treated double mutant mice show accelerated spontaneous tumor development relative to mice that are only homozygous for Trp53tm1Brn and heterozygous for Gt(ROSA)26Sortm1(cre/ERT2)Tyj

homeostasis/metabolism
• after exposure to 4 weekly 2 Gy of total body gamma-irradiation, most tamoxifen-treated adult mice die within 100 days post irradiation




Genotype
MGI:6695305
cn2
Allelic
Composition
Setd4tm1c(KOMP)Wtsi/Setd4tm1c(KOMP)Wtsi
Trp53tm1Brn/Trp53+
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
Genetic
Background
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6N
Cell Lines EPD0225_5_D10
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(cre/ERT2)Tyj mutation (3 available); any Gt(ROSA)26Sor mutation (942 available)
Setd4tm1c(KOMP)Wtsi mutation (0 available); any Setd4 mutation (28 available)
Trp53tm1Brn mutation (18 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
N
• sham-irradiated, tamoxifen-treated mice show no significant differences in spontaneous tumor development or survival relative to mice that are heterozygous for Trp53tm1Brn and Gt(ROSA)26Sortm1(cre/ERT2)Tyj but wild-type for Setd4
• after exposure to 4 weekly 2 Gy of total body gamma-irradiation, tamoxifen-treated adult mice fail to display a delay in the development of radiation-induced thymic lymphomas




Genotype
MGI:6695300
cn3
Allelic
Composition
Setd4tm1c(KOMP)Wtsi/Setd4tm1c(KOMP)Wtsi
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * C57BL/6N
Cell Lines EPD0225_5_D10
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(cre/ERT2)Tyj mutation (3 available); any Gt(ROSA)26Sor mutation (942 available)
Setd4tm1c(KOMP)Wtsi mutation (0 available); any Setd4 mutation (28 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• after exposure to 4 weekly 2 Gy of total body gamma-irradiation, tamoxifen-treated adult mice show delayed thymic lymphoma-mediated death and improved overall survival with a median survival of 245 days versus 195 days in oil-treated controls; 500 days after irradiation, the lymphoma-free survival 22% versus 9.4% in oil-treated controls
• however, non-irradiated tamoxifen-treated adults show no significant differences in survival up to 700 days relative to oil-treated controls

neoplasm
• after exposure to total body gamma-irradiation, tamoxifen-treated adult mice exhibit a lower % of cleaved caspase-3 positive cells in their lymphomas than oil-treated controls
• although radiation-induced T cell lymphomas are largely clonogenic, thymic lymphomas of tamoxifen-treated mice are composed mainly of CD4+ CD8+ double positive cells whereas tumors in oil-treated control mice are largely composed of CD8+ single positive cells
• radiation-induced thymic lymphomas of tamoxifen-treated mice exhibit more chromosomal inversions but fewer deletion events than control tumors
• after exposure to total body gamma-irradiation, tamoxifen-treated adult mice show a more widespread infiltration of peripheral organs (spleen, liver, kidney, and lung) by T-lymphoma cells and a higher tumor dissemination score at the time of death relative to oil-treated controls
• after exposure to total body gamma-irradiation, tamoxifen-treated adult mice that die within the first 195 days post-irradiation show a slight reduction in the size/weight of lymphomas relative to oil-treated controls
• however, no significant difference in primary thymus tumor weight is noted at the time of death
• after exposure to total body gamma-irradiation, tamoxifen-treated adult mice show a significant delay in the development of radiation-induced thymic lymphomas and lymphoma-mediated death relative to oil-treated controls, likely due to slower tumor enlargement in the thymus
• however, non-irradiated tamoxifen-treated adults show no obvious growth retardation or tumor development up to 700 days relative to oil-treated controls

homeostasis/metabolism
• after exposure to 4 weekly 2 Gy of total body gamma-irradiation, tamoxifen-treated adult mice show delayed thymic lymphoma-mediated death and improved overall survival with a median survival of 245 days versus 195 days in oil-treated controls; 500 days after irradiation, the lymphoma-free survival 22% versus 9.4% in oil-treated controls
• however, non-irradiated tamoxifen-treated adults show no significant differences in survival up to 700 days relative to oil-treated controls

cellular
• after exposure to total body gamma-irradiation, tamoxifen-treated adult mice exhibit a lower percentage of cleaved caspase-3 positive cells in their lymphomas than oil-treated controls





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory